Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
| ▸ | PTGER1 | P34995 | 5/20 | 0.45 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.45 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.45 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.43 |
| ▸ | FABP7 | O15540 | 1/20 | 0.43 |
| ▸ | FABP3 | P05413 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.42 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8048666 | 0.88 | SELL (0.45) | SELLSELPPTGER1PTGER4PTGER3 | |
| SCHEMBL20573260 | 0.85 | SELL (0.43) | SELLSELPPTGER1PTGER4PTGER3 | |
| SCHEMBL30563023 | 0.84 | FABP3 (0.56) | FABP7FABP3FABP5RXRARXRB | |
| SCHEMBL1639323 | 0.84 | FABP3 (0.56) | FABP7FABP3FABP5RXRARXRB | |
| SCHEMBL8063672 | 0.82 | CNR2 (0.49) | SELLSELPFABP7FABP3FABP5 | |
| SCHEMBL8059091 | 0.81 | FABP3 (0.46) | FABP7FABP3FABP5ADRA2AADRA2B | |
| SCHEMBL8986479 | 0.80 | FABP3 (0.53) | FABP7FABP3FABP5RXRARXRB | |
| SCHEMBL236823 | 0.80 | FABP3 (0.53) | FABP7FABP3FABP5RXRARXRB | |
| SCHEMBL7017642 | 0.78 | FABP3 (0.44) | FABP7FABP3FABP5CYP2C9LMNA | |
| SCHEMBL19988024 | 0.77 | FABP3 (0.46) | SELLSELPFABP7FABP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012676-B2 | Processes for producing aryl carbamates, isocynates and polyureas using diaryl carbonate | GREAT EASTERN RESINS INDUSTRIAL CO., LTD. (CN) | 2015-04-21 | — | — | US | disclosed |
| US-20130079542-A1 | PROCESSES FOR PRODUCING ARYL CARBAMATES, ISOCYNATES AND POLYUREAS USING DIARYL CARBONATE | NATIONAL CHUNG HSING UNIVERSITY (TW) | 2013-03-28 | — | — | US | disclosed |
| US-6143917-A | FROM A DIARYL CARBONATE AND AN AMINE COMPOUND HAVING AT LEAST ONE HYDROGEN ATOM LOCATED AT AN N-POSITION UNDER MODERATE CONDITIONS AT A HIGH REACTION RATE WITH A HIGH SELECTIVITY AND WITH A HIGH YIELD | UBE INDUSTRIES, LTD. (JP) | 2000-11-07 | — | — | US | disclosed |
| EP-0902014-A1 | PROCESS FOR PRODUCING ARYL CARBAMATES | UBE INDUSTRIES LIMITED (JP) | 1999-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079542-A1 | PROCESSES FOR PRODUCING ARYL CARBAMATES, ISOCYNATES AND POLYUREAS USING DIARYL CARBONATE | UROD, DDC, TST | SELL 4053/4885SELP 1926/4885PTGER1 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.